FDA Inspection
Apotex Inc.Apotex Inc. – FDA Inspection, Apr 11, 2017
Record Details
This FDA Inspection record concerns Apotex Inc., with an inspection on April 11, 2017, issued by the Center for Drug Evaluation and Research, covering drugs.
View Company Profile
ID · 64139ce4-d436-43f7-bb12-a0d8b0366754
Inspection Facts
Voluntary Action Indicated (VAI)
Objectionable conditions were found, but FDA is not prepared to take or recommend regulatory action.
- Inspection number
- 1010679
- FDA center
- Human Drugs
- Project area
- Drug Quality Assurance
- Outcome
- Form 483 issued
FDA Citations
2- 21 CFR 211.113(b)Validation lacking for sterile drug products
- 21 CFR 211.192Investigations of discrepancies, failures
Full citation text and observation details available on the Dashboard.
Other FDA inspections of Apotex Inc.
10| Date | Classification | Office | Project area |
|---|---|---|---|
| May 9, 2025 | OAI | Office of Inspections and Investigations | Drug Quality Assurance |
| March 8, 2024 | NAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| March 24, 2023 | NAI | Center for Drug Evaluation and Research | Bioresearch Monitoring |
| September 14, 2022 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| June 28, 2019 | NAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
Other documents for Apotex Inc.
- FDA Inspection 1269710 - 2025-05-09
- FDA Inspection 1231036 - 2024-03-08
- FDA Inspection 1203170 - 2023-03-24
- FDA Inspection 1179507 - 2022-09-14
- FDA Inspection 1098988 - 2019-06-28
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.